CHF Solutions, Inc. (CHFS) Reached 1-Year Low at $1.85

June 29, 2018 - By Joshua Cleveland

CHF Solutions, Inc. (NASDAQ:CHFS) hit 52 week low with $1.70 target or 8.00 % below the last $1.85 stock price. Barchart.com published the 52 week low on Jun, 29. It has $8.33M market cap. At our $1.70 target, the company worth will be $666,240 less.

The stock decreased 11.90% or $0.25 during the last trading session, touching $1.85.CHF Solutions, Inc. has 392,140 shares volume, 29.62% up from normal. CHFS is downtrending and has moved 75.43% since June 29, 2017. CHFS underperformed by 88.00% the S&P500.

For more CHF Solutions, Inc. (NASDAQ:CHFS) news announced recently go to: Nasdaq.com, Benzinga.com, Nasdaq.com, Globenewswire.com or Benzinga.com. The titles are as follows: “CHF Solutions to Exhibit at the 14th Annual American Association of Heart Failure Nurses Meeting” announced on June 06, 2018, “40 Stocks Moving In Tuesday’s Mid-Day Session” on June 26, 2018, “CHF Solutions, Inc. Hires Additional Field Sales Representatives and Expands Territories” with a publish date: June 20, 2018, “CHF Solutions, Inc. Announces Pricing of Common Stock Offering” and the last “54 Biggest Movers From Yesterday” with publication date: June 27, 2018.

CHF Solutions, Inc., an early-stage medical device company, develops cardiac and coronary disease products primarily in the United States.The firm is worth $8.33 million. It focused on commercializing the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization.Currently it has negative earnings. The firm was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.